Equillium
Equillium is a clinical-stage biotechnology company developing novel products to treat severe autoimmune and inflammatory disorders. The company is based out of La Jolla, California.
Last updated on
About Equillium
Founded
2017Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$15MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541Location
City
La JollaState
CaliforniaCountry
United StatesTech Stack (58)
